Monoclonal antibodies to immunodominant and neutralizing domains of the envelope surface protein of feline immunodeficiency virus

References

1. Ackley C. D., Yamamoto J. K., Levy N., Pedersen N. C., Cooper M. D. 1990; Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. Journal of Virology 64:5652–5655
   [Google Scholar]
2. Avrameas A., Guillet J.-G., Chouchane L., Moraillon A., Sonigo P., Strosberg A. D. 1992; Localisation of three epitopes of the env protein of feline immunodeficiency virus. Molecular Immunology 29:565–572
   [Google Scholar]
3. Barlough J. E., Ackley C. D., George J. W., Levy N., Acevedo R., Moore P. F., Rideout B. A., Cooper M. D., Pedersen N. C. 1991; Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. Journal of Acquired Immune Deficiency Syndromes 4:219–227
   [Google Scholar]
4. Berkower I., Smith G. E., Giri C., Murphey D. 1989; Human immunodeficiency virus 1: predominance of a group specific neutralizing epitope that persists despite genetic variation. Journal of Experimental Medicine 170:1681–1695
   [Google Scholar]
5. Chiang C. S., Grove T., Cooper M., Cuan J., Kowalski A., Parcells K., Tsunokawa M., Rosenberg M., Arcuri E., Franklin S., Smith T., Debouck C. 1989; Development of a confirmatory enzyme-linked immunosorbent assay for HIV-1 antibodies. Clinical Chemistry 35:946–952
   [Google Scholar]
6. De Ronde A, Boers P., Langedijk H., Meloen R., Hesselink W., Keldermans C. E. J. M., van Vliet A., Verschoor E. J., Horzinek M. C., Egberink H. F. 1994; Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198:257–264
   [Google Scholar]
7. Egberink H. F., Borst M., Niphuis H., Balzarini J., Neu H., Schellekens H., De Clercq E., Horzinek M., Koolen M. 1990a; Suppression of feline immunodeficiency virus infection in vivo by 9-(2-phosphonomethoxyethyl)adenine. Proceedings of the National Academy of Sciences, U.S A 87:3087–3091
   [Google Scholar]
8. Egberink H. F., Ederveen J., Montelaro R. C., Pedersen N. C., Horzinek M. C., Koolen M. J. M. 1990b; Intracellular proteins of feline immunodeficiency virus and their antigenic relationship with equine infectious anaemia virus proteins. Journal of General Virology 71:739–743
   [Google Scholar]
9. Egberink H. F., Keldermans C. J. E. M., Koolen M. J. M., Horzinek M. C. 1992; Humoral immune response to feline immunodeficiency virus in cats with experimentally induced and naturally acquired infections. American Journal of Veterinary Research 53:1133–1138
   [Google Scholar]
10. Ishida T., Tomoda I. 1990; Clinical staging of feline immunodeficiency virus infection. Japanese Journal of Veterinary Science 52:645–648
    [Google Scholar]
11. Jarrett O., Yamamoto J. K., Neil J. C. 1990; Feline immunodeficiency virus as a model for AIDS vaccination. AIDS 4: supplement 1 S163–S165
    [Google Scholar]
12. Krone W. J. A., Debouck C., Epstein I. G., Heutink P., Meloen R., Goudsmit J. 1988; Natural antibodies to HIV-tat epitopes and expression of HIV-1 genes in vivo. Journal of Medical Virology 26:261–270
    [Google Scholar]
13. Lombardi S., Garcelli C., La Rosa C., Zaccaro L., Specter S., Malvaldi G., Tozzini F., Esposito F., Bendinelli M. 1993; Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. Journal of Virology 67:4742–4749
    [Google Scholar]
14. Palker T. J., Matthews T. J., Clark M. E., Cianciolo G. J., Randall R. R., Langlois A. J., White G. C., Safai B., Snyderman R., Bolognesi D. P., Haynes B. F. 1987; A conserved region at the COOH terminus of human immunodeficiency virus gpl20 envelope protein contains an immunodominant epitope. Proceedings of the National Academy of Sciences, U.S.A 84:2479–2483
    [Google Scholar]
15. Pedersen N. C., Ho E. W., Brown M. L., Yamamoto J. K. 1987; Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790–793
    [Google Scholar]
16. Prince A. M., Pascual D., Kosolapov L. B., Kurokawa D., Baker L., Rubinstein P. 1987; Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virus. Journal of Infectious Diseases 156:268–272
    [Google Scholar]
17. Rigby M. A., Holmes E. C., Pistello M., Mackay A., Leighbrown A. J., Neil J. C. 1993; Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. Journal of General Virology 74:425–436
    [Google Scholar]
18. Robinson J. E., Holton D., Liu J., Mcmurpo H., Murciano A., Gohd R. 1990; A novel enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to HIV-1 envelope glycoproteins based on immobilization of viral glycoproteins in microtiter plates. Journal of Immunological Methods 132:63–71
    [Google Scholar]
19. Siebelink K. H. J., Chu I., Rimmelzwaan G. F., Weijer K., Van Herwijnen R., Knell P., Egberink H. F., Bosch M. L., Osterhaus A. D. M. E. 1990; Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Research and Human Retroviruses 6:1373–1378
    [Google Scholar]
20. Tilton G. K., O’Connor T. P. Jr Seymour C. L., Lawrence K. L., Cohen N. D., Andersen P. R., Tonelli Q. J. 1990; Immunoassay for detection of feline immunodeficiency virus core antigen. Journal of Clinical Microbiology 28:898–904
    [Google Scholar]
21. Tozzini F., Matteucci D., Bandecchi P., Baldinotti F., Siebelink K., Osterhaus A., Bendinelli M. 1993; Neutralizing antibodies in cats infected with feline immunodeficiency virus. Journal of Clinical Microbiology 31:1626–1629
    [Google Scholar]
22. Weiss R., Clapham P., Weber J., Dalgleish A., Laskey L., Berman P. 1986; Variable and conserved neutralization antigens of the human immunodeficiency virus (HIV-1). Nature; London: 324572–595
    [Google Scholar]